6.60
+0.095(+1.46%)
Currency In USD
| Previous Close | 6.5 |
| Open | 6.5 |
| Day High | 6.63 |
| Day Low | 6.43 |
| 52-Week High | 6.65 |
| 52-Week Low | 2.22 |
| Volume | 320,535 |
| Average Volume | 1.05M |
| Market Cap | 573.74M |
| PE | -5.69 |
| EPS | -1.16 |
| Moving Average 50 Days | 5.18 |
| Moving Average 200 Days | 4.53 |
| Change | 0.1 |
If you invested $1000 in Rezolute, Inc. (RZLT) 10 years ago, it would be worth $80.75 as of August 18, 2025 at a share price of $6.46. Whereas If you bought $1000 worth of Rezolute, Inc. (RZLT) shares 5 years ago, it would be worth $287.11 as of August 18, 2025 at a share price of $6.46.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
GlobeNewswire Inc.
Jul 22, 2025 11:30 AM GMT
REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that management will
Rezolute Announces Presentation of Participant Baseline Data from its Fully Enrolled Phase 3 Study of Ersodetug in Congenital Hyperinsulinism at the Upcoming Annual Meeting of the Endocrine Society (ENDO 2025)
GlobeNewswire Inc.
Jul 09, 2025 11:30 AM GMT
REDWOOD CITY, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism (HI), today announced that the abstrac
Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism
GlobeNewswire Inc.
May 28, 2025 12:00 PM GMT
Target enrollment exceeded with 62 participants enrolled, including approximately 15 percent from U.S. sites Topline data is anticipated in December of 2025 REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezo